연구성과로 돌아가기

2023 연구자 정보 (117 / 1135)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Ryu, Du Yeol
(Ryu, D) ⓘ 		Yonsei Univ, Dept Chem & Biomol Engn, Seoul 120749, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 3.5] Reconfigurable dual-mode optical encryption enabled by block copolymer photonic crystal with micro-imprinted holographic metasurface ⓘ SCIE ⓘ 3.5 MATERIALS SCIENCE, MULTIDISCIPLINARY ⓘ jooyeon.kim@etri.re.kr;cmpark@yonsei.ac.kr; ⓘ
Sarosiek, Tomasz
(Sarosiek, T) ⓘ 		LUX MED Onkol, Warsaw, Poland ⓘ
ⓘ
ⓘ 		[JCR상위 3.5] Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial ⓘ SCIE ⓘ 3.5 MEDICINE, GENERAL & INTERNAL ⓘ x.pivot@icans.eu; ⓘ
Shin, Wonjae
(Shin, W) ⓘ 		교신저자 Ajou Univ, Dept Elect & Comp Engn, Suwon 16499, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 3.5] Rate-Splitting Multiple Access for Downlink MIMO: A Generalized Power Iteration Approach ⓘ SCIE ⓘ 3.5 ENGINEERING, ELECTRICAL & ELECTRONIC;TELECOMMUNICATIONS ⓘ jeonghun.park@knu.ac.kr;jinseokchoi@unist.ac.kr;amyoon@korea.ac.kr;wjshin@ajou.ac.kr;poor@princeton.edu; ⓘ
Shparyk, Yaroslav V.
(Shparyk, YV) ⓘ 		Lviv State Oncol Reg Therapeut & Diagnost Ctr, Lvov, Ukraine ⓘ
ⓘ
ⓘ 		[JCR상위 3.5] Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial ⓘ SCIE ⓘ 3.5 MEDICINE, GENERAL & INTERNAL ⓘ x.pivot@icans.eu; ⓘ
Son, Byung Ho
(Son, BH) ⓘ 		Univ Ulsan, Coll Med, Dept Surg, Asan Med Ctr,Div Breast, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 3.5] Survival Outcomes in Premenopausal Patients With Invasive Lobular Carcinoma ⓘ SCIE ⓘ 3.5 MEDICINE, GENERAL & INTERNAL ⓘ haapybirth@amc.seoul.kr; ⓘ
Song, Im-Sook
(Song, IS) ⓘ 		Kyungpook Natl Univ, Coll Pharm, Vessel Organ Interact Res Ctr, VOICE MRC, 80 Daehak Ro, Daegu 41566, South Korea
Kyungpook Natl Univ, Coll Pharm, BK21 FOUR Community Based Intelligent Novel Drug D, Daegu 41566, South Korea
Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Daegu 41566, South Korea
Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Vessel Organ Interact Res Ctr VOICE,BK21 FOUR Comm, Daegu 41566, South Korea
Kyungpook Natl Univ, Coll Pharm, Daegu, South Korea
Kyungpook Natl Univ, Coll Pharm, Daegu 41566, South Korea
Kyungpook Natl Univ, Coll Pharm, Vessel Organ Interact Res Ctr VOICE, FOUR Community Based Intelligent Novel Drug Discov, Daegu, South Korea
Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Daegu, South Korea ⓘ
ⓘ 		0000-0002-4564-709X
Song, Im-Sook ⓘ 		[JCR상위 3.5] Steppogenin suppresses tumor growth and sprouting angiogenesis through inhibition of HIF-1α in tumors and DLL4 activity in the endothelium
[JCR상위 19.4] Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting
[JCR상위 9.7] Pharmacokinetic modulation of substrate drugs via the inhibition of drug-metabolizing enzymes and transporters using pharmaceutical excipients
[JCR상위 21.2] Toxicokinetics and tissue distribution of phalloidin in mice
[JCR상위 53.0] Application of isothermal chemical denaturation to early-stage formulation development of fibrinogen
[JCR상위 34.9] Gossypetin Prevents the Progression of Nonalcoholic Steatohepatitis by Regulating Oxidative Stress and AMP-Activated Protein Kinase
[JCR상위 5.6] Immunotherapy targeting plasma ASM is protective in a mouse model of Alzheimer's disease ⓘ 		SCIE ⓘ 3.5 CHEMISTRY, MEDICINAL;INTEGRATIVE & COMPLEMENTARY MEDICINE;PHARMACOLOGY & PHARMACY;PLANT SCIENCES
CHEMISTRY, MEDICINAL;PHARMACOLOGY & PHARMACY
PHARMACOLOGY & PHARMACY
FOOD SCIENCE & TECHNOLOGY;TOXICOLOGY
CHEMISTRY, MULTIDISCIPLINARY
MULTIDISCIPLINARY SCIENCES ⓘ 		lym@knu.ac.kr;
legadema0905@knu.ac.kr;minkoochoi@dankook.ac.kr;isssong@knu.ac.kr;
isssong@knu.ac.kr;
maxlim8580@catholic.ac.kr;isssong@knu.ac.kr;legadema0905@knu.ac.kr;minseo.lee@catholic.ac.kr;yongyeon@catholic.ac.kr;joolee@catholic.ac.kr;hckang@catholic.ac.kr;sianalee@catholic.ac.kr;
songimsook1@gmail.com;dhna@cau.ac.kr;
ktk@postech.ac.kr;
hkjin@knu.ac.kr;jsbae@knu.ac.kr; ⓘ
Wang, Yi Victor
(Wang, YV) ⓘ 		제1저자 Chapman Univ, Inst Earth Comp Human & Observing, Orange, CA 92866 USA ⓘ AAJ-9538-2020
Wang, Yi ⓘ 		0000-0003-2228-7009
Wang, Yi Victor ⓘ 		[JCR상위 3.5] Relative Importance of Radar Variables for Nowcasting Heavy Rainfall: A Machine Learning Approach ⓘ SCIE ⓘ 3.5 ENGINEERING, ELECTRICAL & ELECTRONIC;GEOCHEMISTRY & GEOPHYSICS;IMAGING SCIENCE & PHOTOGRAPHIC TECHNOLOGY;REMOTE SENSING ⓘ ywang2@chapman.edu;sekim@chapman.edu;geunsulyu@gmail.com;lchly747@naver.com;gyuwon@knu.ac.kr;kmin@knu.ac.kr;kafatos@chapman.edu; ⓘ
Wojtukiewicz, Marek
(Wojtukiewicz, M) ⓘ 		Bialostockie Cent Onkol Marii Sklodowskiej, Bialystok, Poland ⓘ
ⓘ
ⓘ 		[JCR상위 3.5] Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial ⓘ SCIE ⓘ 3.5 MEDICINE, GENERAL & INTERNAL ⓘ x.pivot@icans.eu; ⓘ
Yoon, Tae In
(Yoon, TI) ⓘ 		제1저자 Dongnam Inst Radiol & Med Sci, Dept Surg, Div Breast Surg, Busan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 3.5] Survival Outcomes in Premenopausal Patients With Invasive Lobular Carcinoma ⓘ SCIE ⓘ 3.5 MEDICINE, GENERAL & INTERNAL ⓘ haapybirth@amc.seoul.kr; ⓘ
Yoon, YeChan
(Yoon, Y) ⓘ 		Samsung Bioepis, Incheon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 3.5] Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial ⓘ SCIE ⓘ 3.5 MEDICINE, GENERAL & INTERNAL ⓘ x.pivot@icans.eu; ⓘ
Abou-Alfa, Ghassan K.
(Abou-Alfa, GK) ⓘ 		Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
Cornell Univ, Dept Med, Weill Med Coll, New York, NY USA ⓘ
ⓘ
ⓘ 		[JCR상위 3.6] Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer The Phase 2b NIFTY Randomized Clinical Trial
[JCR상위 1.7] Outcomes by occurrence of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC) ⓘ 		SCIE ⓘ 1.7 ONCOLOGY ⓘ yooc@amc.seoul.kr; ⓘ
Hyung, Jaewon
(Hyung, J) ⓘ 		제1저자 Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, 88 Olymp Ro,43 Gil, Seoul 05505, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 3.6] Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer The Phase 2b NIFTY Randomized Clinical Trial ⓘ SCIE ⓘ 3.6 ONCOLOGY ⓘ yooc@amc.seoul.kr; ⓘ
Kim, Kyu-pyo
(Kim, KP) ⓘ 		Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, 88 Olymp Ro,43 Gil, Seoul 05505, South Korea ⓘ GQH-5608-2022
Kim, Hyunho ⓘ
ⓘ 		[JCR상위 3.6] Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer The Phase 2b NIFTY Randomized Clinical Trial ⓘ SCIE ⓘ 3.6 ONCOLOGY ⓘ yooc@amc.seoul.kr; ⓘ
An, Zhongnan
(An, ZN) ⓘ 		Huazhong Univ Sci & Technol, Sch Aerosp Engn, Wuhan 430074, Peoples R China ⓘ
ⓘ
ⓘ 		[JCR상위 3.7] Investigating unsteady airflow characteristics in the human upper airway based on the clinical inspiration data ⓘ SCIE ⓘ 3.7 MECHANICS;PHYSICS, FLUIDS & PLASMAS ⓘ xinguang_cui@mail.hust.edu.cn; ⓘ
Chen, Liang
(Chen, L) ⓘ 		Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou 310003, Peoples R China ⓘ
ⓘ
ⓘ 		[JCR상위 3.7] Large eddy simulation study of the airflow characteristics in a human whole-lung airway model ⓘ SCIE ⓘ 3.7 MECHANICS;PHYSICS, FLUIDS & PLASMAS ⓘ xinguang_cui@mail.hust.edu.cn; ⓘ
페이지 이동: